Valion Bio, Inc. (VBIO) Operating margin 2021–2024
Valion Bio, Inc. (VBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-573.8%FY2024 · since FY2021: -448.1% → -573.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -573.8% | +127.3 pp |
| FY2023 | -701.1% | -152.3 pp |
| FY2022 | -548.8% | -100.7 pp |
| FY2021 | -448.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice